NDC 71839-144 – Dalbavancin
Dalbavancin Hydrochloride 500 mg/25mL · Injection, Powder, Lyophilized, For Solution · Intravenous
Product NDC71839-144
Product details
- Brand name
- Dalbavancin
- Generic name
- Dalbavancin
- Labeler
- BE Pharmaceuticals Inc.
- Dosage form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Marketing category
- ANDA · ANDA219604
- Marketed since
- June 12, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- Lipoglycopeptide Antibacterial
Active ingredients
- Dalbavancin Hydrochloride 500 mg/25mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 71839-144-01 | 1 VIAL in 1 CARTON (71839-144-01) / 25 mL in 1 VIAL | Jun 12, 2026 |
Other Dalbavancin products
- 71288-034 Dalbavancin Hydrochloride 500 mg/25mL · Injection, Powder, Lyophilized, For Solution · Meitheal Pharmaceuticals Inc
- 70069-830 Dalbavancin Hydrochloride 500 mg/25mL · Injection, Powder, Lyophilized, For Solution · Somerset Therapeutics, LLC
- 81298-2390 Dalbavancin Hydrochloride 500 mg/1 · Injection, Powder, For Solution · Long Grove Pharmaceuticals, LLC
- 0480-3325 Dalbavancin Hydrochloride 500 mg/25mL · Injection, Powder, For Solution · Teva Pharmaceuticals, Inc.